Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

https://seekingalpha.com/article/4210732-fevertree-panic-selling-warranted

an interesting little article, for which thanks, and of which the following is an extract

Fevertree's shares have always looked rather expensive, commanding a P/E ratio ranging between 50 and 100. What might seem an irrational price tag makes much more sense, considering the growth the company has promised and ultimately delivered. From FY13 to FY17, the company has increased operating profit nearly 2,000% while revenue has risen 726%.

Non-Exec Director and Wife buy’s https://www.moneyam.com/action/news/showArticle?id=6162760

almost sums up the market
having been pounded for the last week and dropping a further 130 at the open, it is now +145 (5.5%)

Directors buy yesterday done the job today

Good chance of bouncing back, overdone.

Action but not clear a Buy or sell, anyone?
https://www.moneyam.com/action/news/showArticle?id=6169913

Looks like a buy taking their holding above 3%.

Morgan Stanley add or sell.. help Skinny again please? https://www.moneyam.com/action/news/showArticle?id=6174124

bear in mind that this remains a very highly rated stock
that said, it's for good reason, so if your pain threshold can withstand what is likely to be some very uncomfortable times ahead, imo this is a BUY but for the longer term

Looks like add Stan, a notification above 3% :-))

Here we go again.

current sipp holding averages out at £10.38 and banked plenty other than that
shall definitely keep holding, for at worst, the company could easily become a t/o target

Very lengthy article in last weeks IC about investing in companies 'Looking at cash flows rather than profits'. Fevertree features heavily in the column as a company which has an ever increasing free cash flow. Lots of data included in the article concerning divi cover, capex ratios, free cash flow yield, cash flow margin & working capital but in summary "High quality, fast growing businesses such as FEVR are rarely available at a cheap price, but even after a significant share price fall over the past few weeks, FEVR still looks expensive on the basis of their free cash flow yield."
Much of the data is beyond me, but I was surprised to learn that "FEVR does not make or distribute it's products. These are outsourced to third parties. This means that the investment requirements of the business in manufacturing and distribution assets are nil."

so where's the bad news?

many people have been holding huge profits, and of course once this sort of share starts to tumble, it doesn't know where to stop, especially in the current climate

No bad news as such, it was just another way of choosing companies in which to invest. On the whole, the writer of the article (Phil Oakley) was pretty impressed with FEVR.

so am i :-)

Re post 652. It's Probably contagion Alf.